Loading…
Lobbying Spend
—
Filings
6
Firms Hired
1
Active Period
2018–2019
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S. 771 and H.R. 1776, Improving Access to Affordable Prescription Drug Act,; HHS/OIG Rule RIN - 936-AA08 entitled, Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S. 771 and H.R. 1776, Improving Access to Affordable Prescription Drug Act,; HHS/OIG Rule RIN - 936-AA08 entitled, Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1316
Improving Access To Affordable Prescription Drugs Act
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S. 771 and H.R. 1776, Improving Access to Affordable Prescription Drug Act,; HHS/OIG Rule RIN - 936-AA08 entitled, Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1776
CREATES Act of 2017
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; HHS Blueprint to lower drug prices and reduce out-of-pocket costs.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2212
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S. 771 and H.R. 1776, Improving Access to Affordable Prescription Drug Act,; HHS/OIG Rule RIN - 936-AA08 entitled, Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $10,000
Matched citations: S.413
Improving Access To Affordable Prescription Drugs Act
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); S. 771 and H.R. 1776, Improving Access to Affordable Prescription Drug Act,; HHS/OIG Rule RIN - 936-AA08 entitled, Removal Of Safe Harbor Protection for Rebates to Plans or PBMs Involving Prescription Pharmaceuticals and Creation of New Safe Harbor Protection.
Client expense: — · Firm income: $10,000
Matched citations: S. 771
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; HHS Blueprint to lower drug prices and reduce out-of-pocket costs.
Client expense: — · Firm income: $10,000
Matched citations: S. 974
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1316
Ensuring Seniors Access to Local Pharmacies Act of 2017
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1939
CREATES Act of 2017
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2212
Prescription Transparency Act of 2018
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 5343-Prescription Transparency Act of 2018; S. 2554-Patient Right to Know Drug Prices Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5343
Phair Pricing Act of 2018
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R.5958
SUPPORT for Patients and Communities Act
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R.6
Ensuring Seniors Access to Local Pharmacies Act of 2017
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: S. 1044
Know the Lowest Price Act of 2018
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: S. 2553
Patient Right to Know Drug Prices Act
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 5343-Prescription Transparency Act of 2018; S. 2554-Patient Right to Know Drug Prices Act
Client expense: — · Firm income: $10,000
Matched citations: S. 2554
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: S.413
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
2018 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.
Client expense: — · Firm income: $10,000
Matched citations: S. 974
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1038
Prescription Drug Price Transparency Act
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1316
Ensuring Seniors Access to Local Pharmacies Act of 2017
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 1316-The Prescription Drug Price Transparency Act (MAC); H.R. 1038 & S.413-Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (DIR); H.R. 1939 & S. 1044 - Ensuring Seniors Access to Local Pharmacies Act of 2017; S. 2553-Know the Lowest Price Act. CY2019 Medicare Part D Final Rule relating to direct and indirect renumeration fees; H.R.5958-The Phair Pricing Act of 2018.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1939
CREATES Act of 2017
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 3528 & S. 2460-Every Prescription Conveyed Securely Act (e-prescribing).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2212
Every Prescription Conveyed Securely Act
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R.6-SUPPORT for Patients and Communities Act; H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; H.R. 3528 & S. 2460-Every Prescription Conveyed Securely Act (e-prescribing).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3528
Prescription Transparency Act of 2018
2018 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 5343-Prescription Transparency Act of 2018; S. 2554-Patient Right to Know Drug Prices Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5343
Source: Senate LDA